ReviewPharmaceuticals (Basel, Switzerland)2025

Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application.

Weihui Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.